BamSEC and AlphaSense Join Forces
Learn More

Avalon Pharmaceuticals Inc

Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.3
from 425 4 pages 2. Interest Rate. From the Date Hereof Until Such Time as All Principal, Interest and Other Amounts Outstanding Hereunder Are Unconditionally and Irrevocably Paid and Performed in Full, Interest Shall Accrue on the Unpaid Principal Amount (Computed on the Basis of the Actual Number of Days Elapsed Over a Year of 365 or 366 Days, as Applicable) Equal to a Fixed Rate of Seven Percent (7.0%) Per Annum. 3. Payments. 3.1 Payment of Principal and Interest. All Outstanding Principal and Accrued Interest Under This Note Shall Be Immediately Due and Payable on the Maturity Date (As Defined Below)
12/34/56
EX-10.3
from 8-K 4 pages 2. Interest Rate. From the Date Hereof Until Such Time as All Principal, Interest and Other Amounts Outstanding Hereunder Are Unconditionally and Irrevocably Paid and Performed in Full, Interest Shall Accrue on the Unpaid Principal Amount (Computed on the Basis of the Actual Number of Days Elapsed Over a Year of 365 or 366 Days, as Applicable) Equal to a Fixed Rate of Seven Percent (7.0%) Per Annum. 3. Payments. 3.1 Payment of Principal and Interest. All Outstanding Principal and Accrued Interest Under This Note Shall Be Immediately Due and Payable on the Maturity Date (As Defined Below)
12/34/56
EX-10.2
from 8-K 2 pages Amendment No. 2 to Term Note
12/34/56
EX-10.2
from 425 2 pages Amendment No. 2 to Term Note
12/34/56
EX-10.1
from 425 3 pages First Amendment to Note Purchase Agreement
12/34/56
EX-10.1
from 8-K 3 pages First Amendment to Note Purchase Agreement
12/34/56
EX-10.1
from 425 2 pages Amendment No. 1 to Term Note
12/34/56
EX-10.1
from 8-K 2 pages Amendment No. 1 to Term Note
12/34/56
EX-10.7
from 8-K 14 pages Intellectual Property Security Agreement
12/34/56
EX-10.7
from 425 14 pages Intellectual Property Security Agreement
12/34/56
EX-10.6
from 425 4 pages Form of Term Note
12/34/56
EX-10.6
from 8-K 4 pages Form of Term Note
12/34/56
EX-10.5
from 425 23 pages Avalon Pharmaceuticals, Inc. $3,000,000 Note Purchase Agreement October 27, 2008 Funds Provided by Clinical Data, Inc
12/34/56
EX-10.5
from 8-K 23 pages Avalon Pharmaceuticals, Inc. $3,000,000 Note Purchase Agreement October 27, 2008 Funds Provided by Clinical Data, Inc
12/34/56
EX-10.4
from 425 16 pages Avalonrx® License Agreement
12/34/56
EX-10.4
from 8-K 16 pages Avalonrx® License Agreement
12/34/56
EX-10.3
from 425 19 pages Registration Rights Agreement
12/34/56
EX-10.3
from 8-K 19 pages Registration Rights Agreement
12/34/56
EX-10.2
from 425 11 pages Common Stock Purchase Warrant to Purchase 1,695,273 Shares of Common Stock of Avalon Pharmaceuticals, Inc
12/34/56
EX-10.2
from 8-K 11 pages Common Stock Purchase Warrant to Purchase 1,695,273 Shares of Common Stock of Avalon Pharmaceuticals, Inc
12/34/56